Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database

British Journal of Clinical Pharmacology

Volumn 69, Issue 3, 2010, Pages 287-294

  Montastruc, Guillaume ^a   Favreliere, Sylvie ^a   Sommet, Agnès ^b,c   Pathak, Atul ^b,c   Lapeyre Mestre, Maryse ^b,c   Perault Pochat, Marie Christine ^a   Montastruc, Jean Louis ^b,c  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Adverse drug reactions; Anthracyclines; Dilated cardiomyopathy; Pharmacoepidemiology; Pharmacovigilance

Indexed keywords

ABACAVIR; AMITRIPTYLINE; CLOBENZOREX; CLOMIPRAMINE; CLOZAPINE; CYCLOPHOSPHAMIDE; DIDANOSINE; EPIRUBICIN; FLUOROURACIL; FLUVOXAMINE; GEMCITABINE; ISOTRETINOIN; LAMIVUDINE; LITHIUM; MITOXANTRONE; OLANZAPINE; PREDNISONE; ZIDOVUDINE;

ADULT; AGED; AGEISM; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DATA BASE; DATA MINING; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; FRANCE; HUMAN; MALE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTHRACYCLINES; CARDIOMYOPATHY, DILATED; DATABASES, FACTUAL; DRUG MONITORING; DRUG TOXICITY; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; YOUNG ADULT;

EID: 76649087704     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03596.x     Document Type: Article

References (39)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J 2008 29 : 270 276.
2. Rodkey SM, Ratliff NB, Youg JB. Cardiomyopathy and myocardial failure. In : Comprehensive Cardiovascular Medicine, ed. Topol EJ. Philadelphia, PA : Lippincott-Raven Publishers, 1998 2589 2620.
3. Feild BJ, Baxley WA, Russel RO Jr., Hood WP Jr., Holt JH, Dowling JT, Rackley CE. Left ventricular function and hypertrophy in cardiomyopathy with depressed ejection fraction. Circulation 1973 47 : 1022 1031.
4. Oakley CM. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980 44 : 672 673.
5. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994 331 : 1564 1575.
6. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 2000 22 : 263 302.
7. Egberts AC, Meyboon RH, De Koning FH, Bakker A, Leufkens HG. Non puerperal lactation associated with antidepressant drug use. Br J Clin Pharmacol 1997 44 : 277 281.
8. Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M, Begaud B. Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol 1998 44 : 513 518.
9. Egberts AC, Meyboom RH, van Puijenbroek EP. Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf 2002 25 : 453 458.
10. Stricker BH, Tijssen JG. Serum sickness-like reactions to cefaclor. J Clin Epidemiol 1992 45 : 1177 1184.
11. Lugardon S, Lapeyre-Mestre M, Montastruc JL. The French Network of PharmacoVigilance Centres. Upper gastrointestinal adverse drug reactions and cyclooxygenase- 2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database. Eur J Clin Pharmacol 2004 60 : 673 677.
12. Moore N, Noblet C, Kreft-Jais C, Lagier G, Ollagnier M, Imbs JL. French PharmacoVigilance Database system: examples of utilization. Therapie 1995 50 : 557 562.
13. WHO. International Monitoring of Adverse Reactions to Drugs: Adverse Reaction Terminology. Uppsala : WHO Collaborating Centre for International Drug Monitoring, 1992.
14. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000 356 : 1255 1259.
15. Ewans SJW. Statistics: analysis and presentation of safety data. In : Stephens' Detection of New Adverse Drug Reactions, 5th edn, eds Talbot J, Waller P. Chichester : Wiley, 2004 301 328.
16. Van der Heijden PG, Van Puijenbroek EP, Van Buuren S, Van der Hofstede JX. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of underreporting on odds ratios. Stat Med 2002 21 : 2027 2044.
17. Wilson AM, Thabane L, Holbrook A. Application of data mining data in pharmacovigilance. Br J Clin Pharmacol 2004 57 : 127 134.
18. Murphy CA, Dargie HJ. Drug-induced cardiovascular disorders. Drug Saf 2007 30 : 783 804.
19. No authors listed. Late cardiotoxicity of anthracyclines. Prescrire Int 1999 8 : 145 146.
20. Feenstra J, Grobbee DF, Remme WJ, Stricker BHCh. Drug-induced heart failure. J Am Coll Cardiol 1999 33 : 1152 1162.
21. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents. Drug Saf 2000 22 : 263 302.
22. Maas SJ, Hill R, Krum H, Liew D, Tonkin A, Demos L, Stephan K, McNeil J. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003. Drug Saf 2007 30 : 47 57.
23. Howland JS, Poe TE, Keith JF Jr. Cardiomyopathy associated with tricyclic antidepressants. South Med J 1983 76 : 1455 1456.
24. Dallack GW, Roose SP, Glassman AH. Tricyclics and heart failure. Am J Psychiatry 1991 148 : 1601.
25. Marti V, Ballester M, Obrador D, Udina C, Moya C, Pons-llado G. Reversal of dilated cardiomyopathy after chronic antidepressant drug withdrawal. Int J Cardiol 1995 48 : 192 194.
26. Briec F, Delaire C, Bouhour JB, Trochu JN. Recurrence of dilated cardiomyopathy after reintroduction of a tricyclic antidepressant. Arch Mal Coeur Vaiss 2006 99 : 933 935.
27. Roos JC. Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine. Br J Clin Pharmacol 1983 15 (Suppl. 3 439S 445S.
28. Monsuez JJ, Gallet B, Escaut L, Pulik M, Charniot JC, Merad M, Slama M, Weber S, Vittecoq D. Cardiac side effects of anti-HIV agents. Arch Mal Coeur Vaiss 2000 93 : 835 840.
29. Frerichs FC, Dingemans KP, Brinkman K. Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors. N Engl J Med 2002 347 : 1895 1896.
30. Tanuma J, Ishizaki A, Gatanaga H, Kikuchi Y, Kimura S, Hiroe M, Oka S. Dilated cardiomyopathy in adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen. Clin Infect Dis 2003 37 : 109 111.
31. Miro O, Lopez S, Cardellach F, Casademont J. Mitochondrial studies in HAART-related lipodystrophy: from experimental hypothesis to clinical findings. Antivir Ther 2005 10 (Suppl. 2 M73 81.
32. Cornaert P, Camblin J, Graux P, Anaye B, Dutoit A, Croccel L. Congestive cardiomyopathy in addition to clobenzorex, an anorexigenic drug. Arch Mal Coeur Vaiss 1986 79 : 515 518.
33. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Begaud B. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med 1996 335 : 609 616.
34. Weissman NJ. Appetite suppressants and valvular heart disease: a systematic review. BMC Clin Pharmacol 2002 2 : 6.
35. Jacobs LJ. Reversible dilated cardiomyopathy induced by methamphetamine. Clin Cardiol 1989 12 : 725 727.
36. Stadler WM, Kuzel T, Dumas M, Vogelzang NJ. Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal cell carcinoma. J Clin Oncol 1998 16 : 1820 1825.
37. Klein SK, Biemond BJ, Van Oers MHJ. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA). Ann Hematol 2007 86 : 917 918.
38. Aichhorn W, Huber R, Stuppaech C, Whitworth AB. Cardiomyopathy after long-term treatment with lithium: more than a coincidence? J Psychopharmacol 2006 20 : 589 591.
39. Coulter DM, Bate A, Meyboom RHB, Lindquist M, Edwards IR. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. BMJ 2001 322 : 1207 1209.